2 June 2021

At the meeting of 5 May 2021 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
asbestosis 59/2021 60/2021
gastro-oesophageal reflux disease 61/2021 62/2021
IgA nephropathy 63/2021 64/2021
malignant neoplasm of the oral cavity, oropharynx and hypopharynx 65/2021 66/2021
pes planus 67/2021 68/2021
porphyria cutanea tarda 69/2021 70/2021


Note: The investigation concerning 'mesangial IgA glomerulonephritis' has resulted in the determination of Statements of Principles concerning IgA nephropathy.

Determined New Statements of Principles (SOPs) for:

Condition SOPs
transverse myelitis 71/2021 72/2021
hypogonadism 73/2021 74/2021

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
non-Hodgkin lymphoma 75/2021 76/2021

The above SOPs take effect from 21 June 2021.

Summary of Changes

Completed Investigations

The above determinations conclude the previously advertised investigations into:

New Investigations

Decided to advertise the following investigations:

The above investigation notices appear in the Government Notices Gazette of 1 June 2021.